Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).
The authors respond to a critique of their prior article, elaborating on how "a switch from fossil fuel systems to renewables involves sharp declines in risk and mining."
Reversing a more typical pattern of using existing security ties to attract investors, Guyana and Qatar have demonstrated how two small states can use foreign direct investment by oil and gas firms to bolster security ties with the U.S., writes energy fellow Jim Krane in a new article for Resources Policy.
The evidence base on health services use and cost burdens associated with transition to severe cognitive impairment (SCI) and dementia is underdeveloped. We examine how the change in cognitive impairment status influences nursing home use, hospitalizations, and out-of-pocket (OOP) expenditures.
An emerging perspective in U.S. public discourse claims that a buildout of renewable electricity would exacerbate supply risks, mining intensity, and import dependence. This ScienceDirect article from fellow Jim Krane and graduate student Robert Idel contends the opposite is true, demonstrating how transitioning to renewables hugely reduces the materials, mining and political risk involved compared to coal.
Vaginitis is one of the most common reasons women access health care in the United States. Despite its prevalence and disruptive impact, it is frequently misdiagnosed and untreated, resulting in unnecessary patient discomfort, follow-up visits, and health care costs.
Argentina is a risky place for foreign investors. But the country’s Vaca Muerta offers a case study on how unconventional shale gas investment may be lower risk, with implications that could spur shale production outside the U.S.
Gabriel Collins, Mark P. Jones, Jim Krane, Kenneth B. Medlock III, Francisco J. MonaldiAugust 12, 2021